The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study

• Ngā kaituhi matua: Kosuke Hiramatsu (Author), Yutaka Ueda (Author), Asami Yagi (Author), Akiko Morimoto (Author), Tomomi Egawa-Takata (Author), Satoshi Nakagawa (Author), Eiji Kobayashi (Author), Toshihiro Kimura (Author), Tadashi Kimura (Author), Ryoko Minekawa (Author), Yumiko Hori (Author), Kazuaki Sato (Author), Eiichi Morii (Author), Tomio Nakayama (Author), Yoshimichi Tanaka (Author), Yoshito Terai (Author), Masahide Ohmichi (Author), Tomoyuki Ichimura (Author), Toshiyuki Sumi (Author), Hiromi Murata (Author), Hidetaka Okada (Author), Hidekatsu Nakai (Author), Noriomi Matsumura (Author), Masaki Mandai (Author), Jyunko Saito (Author), Yorihiko Horikoshi (Author), Tetsu Takagi (Author), Takayuki Enomoto (Author), Kentaro Shimura (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Human papillomavirus (HPV) vaccine has been used to prevent chronic HPV infection, which accounts for cervical cancer. Japanese Ministry of Health, Labor and Welfare (MHLW) conducted an HPV vaccination campaign in 2010 and the Obstetrical Gynecological Society of Osaka initiated a multicenter, prosp...